日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MCM10, a novel YAP1/TEAD4 target, drives gastric cancer progression by bridging DNA replication to stemness acquisition

MCM10 是一种新型的 YAP1/TEAD4 靶点,它通过连接 DNA 复制和干细胞特性获得来驱动胃癌的进展。

Xie, Fuda; Leung, Hoi Wing; Lyu, Yang; Yu, Peiyao; Feng, Tiejun; Chen, Bonan; Wu, Jialin; Tham, Jenson; Fang, Canbin; Cheung, Alvin H K; Chow, Chit; Jiang, Jianhui; Hu, Jintao; Zhang, Fengbin; Zhu, Chaowei; Zhong, Keli; Sun, Meiheng; Zhang, Ge; Yu, Sifan; Xu, Dazhi; Wang, Shouyu; Huang, Bing; Zhuang, Kangmin; Luo, Xiaobei; Li, Aimin; Guo, Qing; Gao, Chanchan; Zhang, Bin; Ma, Yuan; Wu, William Kk; An, Liwei; Wong, Chi Chun; Yu, Jun; To, Ka Fai; Kang, Wei

Should direct-acting antiviral be considered for all patients with HCV-related hepatocellular carcinoma?: Reply to correspondence on "Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study"

对于所有丙型肝炎病毒相关肝细胞癌患者,是否应考虑使用直接抗病毒药物?:对“丙型肝炎病毒相关肝细胞癌患者的直接抗病毒治疗:一项全国性队列研究”一文的回复

Ong, Yan Ling; Kaewdech, Apichat; Wong, Yu Jun

Editorial on "Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study"

关于“直接抗病毒疗法治疗丙型肝炎相关肝细胞癌患者:一项全国性队列研究”的社论

Ong, Yan Ling; Kaewdech, Apichat; Huang, Daniel Q; Wong, Yu Jun

Correction: FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis

更正:FOXP4 是 YAP1 的直接靶点,可促进胃癌干细胞特性并驱动转移。

Liu, Xiaoli; Chen, Bonan; Xie, Fuda; Wong, Kit Yee; Cheung, Alvin H K; Zhang, Jinglin; Wu, Qian; Fang, Canbin; Hu, Jintao; Wang, Shouyu; Xu, Dazhi; Chen, Jianwu; Wang, Yuzhi; Wong, Chi Chun; Chen, Huarong; Wu, William K K; Yu, Jun; Chan, Michael W Y; Tsang, Chi Man; Lo, Kwok Wai; Tse, Gary M K; To, Ka-Fai; Kang, Wei

Fast-swimming biohybrid OstraBot with self-trained high-strength muscles

拥有自训练高强度肌肉的快速游泳生物混合机器人OstraBot

Chen, Pengyu; Wang, Xuchen; Zhou, Jinrun; Tan, Yu Jun

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial

在中国晚期胰腺腺癌患者中,NALIRIFOX 对比吉西他滨联合白蛋白紫杉醇:一项随机、开放标签的 II 期试验

Gao, Chuntao; Zhang, Yanqiao; Qu, Xiujuan; Chen, Xingyun; Zhang, Jingdong; Wu, Heshui; Sun, Meili; Zha, Yong; Wang, Junbin; Wang, Yusheng; Li, Zhihua; Gao, Jinghua; Lin, Rongbo; Zang, Aimin; Zhang, Huiqing; Yuan, Xianglin; Du, Chengyou; Zhao, Jun; Yang, Yongsheng; Shi, Xuetao; Cheng, Wei; Wang, Bangmao; Wu, Shikai; Zhao, Tiansuo; Wang, Jian; Gao, Song; Wang, Xiuchao; Ma, Weidong; Liu, Rui; Shi, Yehui; Liu, Yanping; Xie, Yijiao; Niu, Miao; Zhao, Fuchen; Yu, Jun; Hao, Jihui

A testis-specific E3 ubiquitin ligase complex governs spermiogenesis and male fertility

睾丸特异性E3泛素连接酶复合物调控精子发生和男性生育能力

Wu, Tiantian; Tu, Chaofeng; Feng, Yuxuan; Qu, Wenying; Chen, Jinyi; Wu, Huan; Gao, Wenxin; Xu, Bingya; Yu, Xiangling; Bao, Mingyuan; Xu, Jinfu; Zhou, Nianchao; Hu, Haoyue; Jiang, Bing; Xie, Qingsong; Meng, Lanlan; Tan, Chen; Lin, Ge; Shen, Cong; Chen, Xia; Guo, Yueshuai; Zhou, Tao; Liang, Yuting; Hua, Rong; Cao, Yunxia; Liu, Mingxi; Yu, Jun; Huang, Xiaoyan; Tan, Yue-Qiu; Zheng, Bo

Commentary on "Neg-entropy is the true drug target for chronic diseases"

关于“负熵是慢性疾病的真正药物靶点”的评论

Coker, Olabisi; Yu, Jun

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study

胰腺导管腺癌预后及CA19-9阻断的病理组学特征:一项真实世界多中心研究

Chen, Qiangda; Xu, Zhihang; Zou, Yiping; Jiang, Zhenlai; Li, Yecheng; He, Taochen; Yin, Hanlin; Li, Jiali; An, Yanfei; Han, Jiande; Xie, Yuqi; Gan, Wei; Xu, Yaolin; Wang, Wenquan; He, Junyi; Wang, Haibo; Wu, Wenchuan; Ye, Zhenyu; Lou, Wenhui; Hao, Jihui; Liu, Liang; Yu, Jun; Pu, Ning

From Grave to Cradle: Kombucha Waste for Sustainable Electronics

从坟墓到摇篮:康普茶废料助力可持续电子产品

Chan, Xin Ying; Sun, Xiaolu; Pang, Eddy Yi Ler; Ren, Iris Zhiyu; Zhang, Xuan; Chen, Pengyu; Tan, Yu Jun